Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Yu Cheng Zhao (NPI 1447647375)

Field	Value
Entity Type	Individual
Organization	Yu Cheng Zhao
Address	1000 Wall St
City	Ann Arbor
State	MI
ZIP	48105
Taxonomy	Ophthalmology Physician
NPI Enumerated	April 17, 2015

Payer Source	Total Paid
Medicare	$618.5K
Medicaid	$0

Key Findings

The provider’s Medicare activity is dominated by intravitreal drug administrations and retina-focused procedures: J0178 (437 claims, $684 avg paid/claim, $298.9K revenue, 48.3% of Medicare revenue) and J2777 (3K claims, $29 avg paid/claim, $87.6K revenue, 14.2%) appear as primary revenue drivers, supported by procedure code 67028 (596 claims, $98 avg paid/claim, $58.4K revenue, 9.4%) and high-volume retinal imaging (92134, 1.5K claims, $29 avg paid/claim, $42.7K revenue). This mix points to an operational focus on intravitreal injection clinics and retina disease monitoring rather than general ophthalmology surgical volume.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 76.2% of this provider's total Medicare revenue, with J0178 alone representing 48.3% of Medicare revenue. That concentration indicates financial sensitivity to reimbursement or utilization changes for a very small set of services.

Payer mix is effectively single-payer: Total Medicare revenue: $618.5K while Medicaid shows none (no Medicaid billing on file). With no Medicaid billing, the provider’s realized revenue and utilization profile should be considered Medicare-centric for capacity planning and network impact assessments.

Although injections drive revenue dollars, the provider’s national standing on those drug codes is modest: J0178 ranks #2052 of 3204 providers nationally (36th percentile; typical, unremarkable volume) and J2777 ranks #1837 of 2039 (10th percentile; typical, unremarkable volume). Those percentiles indicate the practice is not a national outlier in anti-VEGF drug volume despite the dollar concentration in J0178.

Clinical throughput and evaluation-management services are a relative strength: 99214 has 912 claims, $93 avg paid/claim, $84.8K revenue and ranks #14400 of 479517 (97th percentile; notably above typical national volume), while 92134 ranks #1548 of 26868 (94th percentile; notably above typical national volume). High percentiles on 99214 and 92134 suggest robust follow-up visit and imaging activity consistent with ongoing retina disease management and frequent patient monitoring.

The revenue profile shows sensitivity to drug unit pricing as well as volume: J0178’s relatively high avg paid/claim ($684) and $298.9K revenue contrast with J2777’s low avg paid/claim ($29) but large claim count (3K claims, $87.6K revenue). Operational and revenue forecasts should therefore account for both per-unit reimbursement and claim-count dynamics when modeling future Medicare revenue.

Tenure: the provider’s NPI was enumerated 2015-04-17 (~11 years ago), which provides a multi-year window for developing a stable Medicare patient panel and refining an injection/imaging workflow. This length of enrollment supports the plausibility of established clinical pathways for retina care reflected in current billing.

The absence of any Medicaid billing on file limits visibility into state-program exposure and suggests limited participation in Medicaid networks; payers and contracting teams should treat this provider as primarily Medicare-facing when estimating network adequacy or negotiating participation terms.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

12 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	440	$680	$298.9K
J2777	Injection, faricimab‑svoa, 0.1 mg	3,020	$30	$87.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	910	$90	$84.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	600	$100	$58.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,470	$30	$42.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	250	$70	$16.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	180	$90	$15.7K
J9035	Injection, bevacizumab, 10 mg	140	$60	$7.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	30	$110	$3.6K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	70	$20	$1.6K

Showing 1–10 of 12

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Yu Cheng Zhao — 2 of 12 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

12 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	9	110	680	$690	$630.2K
J2777	8	60	7,200	$30	$321K
67028	8	160	440	$90	$57.6K
92014	100	1,080	100	$80	$14.8K
99214	34	15,470	80	$80	$11.4K
J9035	6	30	70	$50	$9.5K
92134	6	820	60	$30	$7.1K
99213	371	14,810	60	$60	$6.6K
99204	657	6,280	30	$110	$4.2K
92250	96	750	50	$20	$2.6K

Showing 1–10 of 12

Related Providers

Other providers that share a Tax Identification Number (TIN) with Yu Cheng Zhao, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Regents Of The University Of Michigan	MI	General Acute Care Hospital	$0	$317.9M
Regents Of The University Of Michigan	MI	Home Infusion Therapy Pharmacy	$0	$33.8M
Regents Of The University Of Michigan	MI	Diagnostic Radiology Physician	$0	$13.8M
Regents Of The University Of Michigan	MI	Neonatal-Perinatal Medicine Physician	$0	$12.9M
Regents Of The University Of Michigan	MI	Emergency Medicine Physician	$0	$12.7M
Regents Of The University Of Michigan	MI	Obstetrics & Gynecology Physician	$0	$12.5M
Regents Of The University Of Michigan	MI	Family Medicine Physician	$0	$11.2M
Regents Of The University Of Michigan	MI	Pediatrics Physician	$0	$8.3M
Regents Of The University Of Michigan	MI	Anesthesiology Physician	$0	$7M
Regents Of The University Of Michigan	MI	Pediatric Critical Care Medicine Physician	$0	$6.6M

Nearby Providers

Other providers in the same ZIP code as Yu Cheng Zhao, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Micholdings, Inc.	MI	Adult Mental Health Clinic/Center	$0	$38.1M
Iha Health Services Corporation	MI	Urgent Care Clinic/Center	$0	$9.1M
Regents Of The University Of Michigan	MI	Ophthalmology Physician	$0	$5.9M
Cascade Hemophilia Consortium	MI	Specialty Pharmacy	$5.1M	$0
Christopher Conrady	MI	Ophthalmology Physician	$818.6K	$0
Brett Malbin	MI	Ophthalmology Physician	$477.6K	$0
Nicholas Behunin	MI	Ophthalmology Physician	$309.1K	$0
Ross Halpern	MI	Psychologist	$296.7K	$0
Christopher Hood	MI	Ophthalmology Physician	$222.4K	$0
Woodward Detroit Cvs, L.L.C.	MI	Pharmacy	$164.9K	$0

Yu Cheng Zhao — Billing Profile & Reimbursement Data

Sign up for Yu Cheng Zhao — Billing Profile & Reimbursement Data policy alerts

Yu Cheng Zhao — Billing Profile & Reimbursement Data

Sign up for Yu Cheng Zhao — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References